Back to Authors

Cheah, Alison L.

Mayo Clinic

Douglass Hanly Moir Pathology

Citations 3

PRRX1-rearranged Fibroblastic Tumors
Torres‐Mora, Jorge , Thangaiah, Judith Jebastin, Oliveira, André M. , Malik, Faizan , Din, Nasir Ud , Hassan, Usman , Maqbool, Hina , Caragea, Mara, Schubart, Christian, Grundtmann, Bo, Melchior, Linea Cecilie , Talman, Maj‐Lis, Cheah, Alison L., Thway, Khin , Fisher, Cyril , Torres-Mora, Jorge, Oliveira, Andre, Dehner, Carina , Michal, Michael , Obeidin, Farres , Lee, Cheng‐Han , Schubart, Christian, Agaimy, Abbas , Gross, John , Antonescu, Cristina R. , Linos, Konstantinos

American Journal of Surgical Pathology | October 2, 2025 | Volume: 50 | Issue: 1 | Pages: 31-40

10.1097/pas.0000000000002472 Get It

With the first series of PRRX1 -rearranged tumors published in 2019, the spectrum of these so-called fibroblastic tumors has been expanded. Since then, several smaller case series have been published; however, our understanding of them continues to be quite limited given their rarity. We herein studied 18 additional cases, the largest series to date. Eighteen tumors present in 9 male, 8 female, and 1 nonbinary patient with a median age of 35 years (range: 11 to 70 y) and involved the neck (5), the chest region (4), thigh (3), back (1), shoulder (1), forehead (1), lower leg (1), axilla (1), and the parapharyngeal region (1). Clinical follow-up (9/18 tumors; 50%; median: 10 mo; range: 4 to 40 mo) showed consistent indolent behavior without local recurrences or distant metastases. On morphology, these tumors were characterized by well-circumscription and distinctive peripheral crescent-shaped vessels. They were composed of uniform spindle and round cells growing in short fascicles within often densely hyalinized collagen lacking significant mitotic activity, necrosis, or cytologic atypia. Immunohistochemically, about half of the tested tumors expressed focal to rarely diffuse S100 with occasional co-expression of SOX10. Interestingly, almost half of the tested cases also showed complete loss of RB expression. All but 1 tumor harbored a PRRX1::NCOA1 fusion, while 1 case harbored a novel PRRX1::EP300 fusion. We herein provide additional data on these exceptionally uncommon tumors, expand their molecular spectrum, and compare them to their close morphologic mimics to aid in accurate diagnosis and avoid confusion with potentially more aggressive neoplasms.
Desmoplastic Small Round Cell Tumors With Atypical Presentations: A Report of 34 Cases
Al‐Ibraheemi, Alyaa , Broehm, Cory , Tanas, Munir R. , Horvai, Andrew , Cheah, Alison L., Thway, Khin , Fisher, Cyril , Bahrami, Armita , Folpe, Andrew L. , Fritchie, Karen , Thway, Khin , Fritchie, Karen J. , Rubin, Brian P.

International Journal of Surgical Pathology | December 7, 2018 | Volume: 27 | Issue: 3 | Pages: 236-243

10.1177/1066896918817140 Get It

Objectives. Desmoplastic small round cell tumor (DSRCT) is an aggressive round cell sarcoma that arises in the abdominal cavity/pelvis of young males. We sought to expand its clinicopathologic spectrum. Methods. Cases of DSRCT presenting in patients >30 years of age or tumors arising outside of the abdominal cavity/pelvis were retrieved. Results. Thirty-four cases were identified. Sixteen tumors arose at atypical sites (head/neck, intracranial, thigh, axilla/shoulder, inguinal/paratesticular, intraosseous, and uterine corpus). The remaining 18 patients were older than 30 years, and their tumors involved the abdomen or pelvis. The majority of cases showed areas with classic histology, while 6 cases exhibited solid growth and 5 showed macronodular architecture. Cytologic appearance included round cell, rhabdoid, epithelioid, and small cell. Conclusion. DSRCT may arise at nonabdominal locations in both pediatric and adult populations, as well as intra-abdominally in older adults, and these tumors exhibit high rates of metastasis and morbidity.
Primary clear cell sarcoma of the head and neck: a case series with review of the literature
Feasel, Patrick, Cheah, Alison L., Fritchie, Karen , Winn, Brody, Piliang, Melissa , Billings, Steven D.

Journal of Cutaneous Pathology | June 6, 2016 | Volume: 43 | Issue: 10 | Pages: 838-846

10.1111/cup.12755 Get It

BackgroundClear cell sarcoma typically arises in deep soft tissues of the foot/ankle. Primary head and neck clear cell sarcoma is rare. We report three molecularly confirmed primary head and neck clear cell sarcoma and review the literature.MethodsHead and neck clear cell sarcoma with no primary elsewhere were retrieved from archival/consultation files. English language literature review of all reported head and neck clear cell sarcoma was performed.ResultsThree cases were identified. The tumors, all in men, presented on the scalp of a 33‐year‐old, face of a 20‐year‐old and tongue of a 44‐year‐old. Tumors ranged from 0.6 to 1.4 cm. All had typical features of clear cell sarcoma, including nests of tumor cells divided by fibrous septae. One had multinucleated wreath‐like giant cells. One had a focal junctional component. Immunohistochemistry was positive for S100 (three out of three), HMB45 (three out of three) and Melan‐A (two out of three). All had EWSR1 rearrangements by fluorescence in situ hybridization. Follow up available for one patient revealed no evidence of disease after wide excision and radiation. Seven additional reported cases were identified and tabulated.ConclusionHead and neck clear cell sarcoma is rare but should be considered in the differential diagnosis of nested tumors with fibrous septae. Molecular analysis should be considered for definitive diagnosis regardless of location.